This study explored the downstream effects of overexpressing the Klotho gene, which has an antitumor effect on resistant human colon cancer cells, focusing on its action on TRAIL death and decoy (DcR1 and DcR2) receptors. The gene discussed is KL; the disease is colonic neoplasm.